反应条件
Stage #1: <a href="#" onclick="return RXDsubstances(event, this, '15414034', constants.ctx, '0')">3-(Ethyl(phenyl)amino)-3-oxopropanoic acid</a> <b>With</b> <a href="#" onclick="return RXDsubstances(event, this, '103233', constants.ctx, '0')">pyridine</a> <b>in</b> <a href="#" onclick="return RXDsubstances(event, this, '1730800', constants.ctx, '0')">dichloromethane</a> <br />T=20 - 25°C; 0.5 h; Inert atmosphere; <br />Stage #2: <b>With</b> <a href="#" onclick="return RXDsubstances(event, this, '385668', constants.ctx, '0')">pivaloyl chloride</a> <b>in</b> <a href="#" onclick="return RXDsubstances(event, this, '1732393', constants.ctx, '0')">dichloro difluoro methane</a> <br />T=0 - 5°C; 1 h; <br />Stage #3: <a href="#" onclick="return RXDsubstances(event, this, '22559043', constants.ctx, '0')">methyl 2-chloro-6-methylaminobenzoate</a> <b>in</b> <a href="#" onclick="return RXDsubstances(event, this, '1730800', constants.ctx, '0')">dichloromethane</a> <br />T=0 - 20°C; Product distribution / selectivity; <br /> <br />
参考文献
MAPI PHARMA LTD.; MAROM, Ehud; MIZHIRITSKII, Michael; RUBNOV, Shai Patent: WO2012/70051 A1, 2012 ; Location in patent: Page/Page column 24-25 ;